Cardiovascular outcomes, long-term efficacy and safety In people with T2D and established cardiovascular disease, the international guidelines for T2D recommend the use of GLP-1 RA or sodium glucose co-transporters 2 inhibitors (SGLT-2i) as first-line treatment (independent of HbA1c), based on multiple trials demonstrating their cardio-renal benefits [109]
The GI side effect timeline provides benchmarks for normal duration versus concerning persistence
BY REGION The GLP-1 agonists market covers North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa
A probiotic specifically designed for GLP-1 users addresses the gut microbiome changes that both Hashimoto's and GLP-1 medications create
However, this slower digestion is also the primary reason for symptoms like nausea, bloating, and changes in bowel habits that people experience
What Other Review Sites Say Going through the quiz gave me a sense of how Remedy Meds starts the process, but I wanted to know more about what patients actually experience